Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100RJUD
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥737m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥891m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥891m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥36.1bnat 2023-06-30Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥28.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥23.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.5bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥73.662023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio35.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥86m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥70m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥15m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥212m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥328m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2023-04-01 → 2023-06-30¥875m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥269m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥137m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-06-30¥36m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥453m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥277m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥176m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥174m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-06-30¥5.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥4.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥758m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥774m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥370m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥359m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥40m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥483m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥256m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥38m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 402
ItemContextValueUnit
Loss on investment of securities noePrior1YTDDuration134000000JPY
Loss on investment of securities noeCurrentYTDDuration34000000JPY
Commission fee noePrior1YTDDuration66000000JPY
Commission fee noeCurrentYTDDuration1000000JPY
Cost of lease revenue noePrior1YTDDuration0JPY
Cost of lease revenue noeCurrentYTDDuration58000000JPY
Other noePrior1YTDDuration4000000JPY
Other noeCurrentYTDDuration21000000JPY
Non operating expensesPrior1YTDDuration237000000JPY
Non operating expensesCurrentYTDDuration160000000JPY
Ordinary incomePrior1YTDDuration1432000000JPY
Ordinary incomeCurrentYTDDuration1066000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration59000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration117000000JPY
Extraordinary incomePrior1YTDDuration59000000JPY
Extraordinary incomeCurrentYTDDuration117000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration－JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration3000000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration3000000JPY
Income before income taxesPrior1YTDDuration1492000000JPY
Income before income taxesCurrentYTDDuration1179000000JPY
Income taxes currentPrior1YTDDuration379000000JPY
Income taxes currentCurrentYTDDuration183000000JPY
Income taxes deferredPrior1YTDDuration38000000JPY
Income taxes deferredCurrentYTDDuration104000000JPY
Income taxesPrior1YTDDuration418000000JPY
Income taxesCurrentYTDDuration288000000JPY
Profit lossPrior1YTDDuration1074000000JPY
Profit lossCurrentYTDDuration891000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1067000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration891000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration6000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration48000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration56000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration18000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration15000000JPY
Other comprehensive incomePrior1YTDDuration66000000JPY
Other comprehensive incomeCurrentYTDDuration71000000JPY
Comprehensive incomePrior1YTDDuration1140000000JPY
Comprehensive incomeCurrentYTDDuration963000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1133000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration963000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration6000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember2907000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember1265000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember359000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember256000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass